AmeriPath, a subsidiary of Quest Diagnostics, is a leading national provider of diagnostic healthcare information. The company specializes in delivering critical disease diagnoses to physicians and their patients, ensuring accurate and timely disease management solutions. AmeriPath's services are supported by a large, specialized team of board-certified pathologists with expertise in various fields such as breast pathology, cytology, gastrointestinal pathology, genitourinary pathology, gynecological pathology, hematopathology, and surgical pathology. The company operates within the healthcare sector, serving a diverse range of clients including individual patients, healthcare providers, and insurance companies. AmeriPath's business model revolves around providing high-quality diagnostic services that help in making informed clinical decisions. The company generates revenue through its extensive managed care contracts and broad health plan coverage, which minimize out-of-pocket expenses for patients. AmeriPath's commitment to quality and safety has made it the largest pathology organization in the nation, dedicated to delivering the highest standards of diagnostic excellence.

Keywords: diagnostic healthcare, disease diagnosis, pathology, board-certified pathologists, clinical decisions, healthcare sector, managed care contracts, health plan coverage, quality and safety, Quest Diagnostics.